Use of antibodies to sialidase as anti-infectious agents and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/35 (2006.01) A61K 31/70 (2006.01) A61K 31/7012 (2006.01) A61K 31/7028 (2006.01) A61K 39/21 (2006.01) A61P 29/00 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2269533

Sialic acids have the ability to prevent hyposialylation of cells as competitive inhibitors of endogenous sialidase. It is now also possible to develop antibodies to mammalian sialidase that significantly reduce influx of neutrophils into inflammatory sites.

Les acides sialiques ont la capacité d'empêcher l'hyposialylation des cellules en tant qu'inhibiteurs compétitifs de la sialidase endogène. Il est maintenant possible également de mettre au point des anticorps contre la sialidase mammalienne qui réduisent de manière significative l'afflux de neutrophiles sur les sites inflammatoires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of antibodies to sialidase as anti-infectious agents and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of antibodies to sialidase as anti-infectious agents and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of antibodies to sialidase as anti-infectious agents and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2068472

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.